AN EXCITING EARLY STAGE INVESTMENT OPPORTUNITY
The 24th February 2016 was an exciting day for us at LeafCann. The passing of Narcotic Drugs Amendment Bill the Commonwealth Parliament means significant opportunities are opening up for Australian patients and the Australian economy.
LeafCann is well positioned to respond to the changing regulatory landscape and take advantage of the commercial opportunities that come with being first to market in this new medical cannabis industry.
Our expert team has ensured that LeafCann’s regulatory affairs, quality assurance, security planning and overall business strategy are all in place.
Now we’re looking forward to moving ahead with the next stage of becoming a leading industry brand, thought leader and innovator. There’s never been a better time to invest in alternative medicine.